Vaishali Pharma Limited (NSE:VAISHALI)
India flag India · Delayed Price · Currency is INR
6.87
-0.36 (-4.98%)
Oct 23, 2026, 3:29 PM IST

Vaishali Pharma Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
-11.0917.1114.575.2911.62
Cash & Short-Term Investments
14.311.0917.1114.575.2911.62
Cash Growth
-22.39%-35.19%17.41%175.35%-54.48%270.76%
Accounts Receivable
-507.73467.17494.28536.1585.05
Other Receivables
-10.484.665.133.723.18
Receivables
-518.2471.83499.41539.82588.23
Inventory
-34.0148.13.830.56.29
Prepaid Expenses
--0.570.430.530.69
Other Current Assets
-566.33507.24227150.57157.45
Total Current Assets
-1,1301,045745.2726.71764.29
Property, Plant & Equipment
-11.5411.6114.5517.989.04
Long-Term Investments
-68.8317.5317.5316.3810.82
Other Intangible Assets
-7.869.238.028.567.69
Long-Term Deferred Tax Assets
-1.531.841.761.431.61
Other Long-Term Assets
-14.4913.412.5117.9222.81
Total Assets
-1,2341,098799.56788.98816.24

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
-211.77271.45193.89179.97283.81
Accrued Expenses
-7.22-0.3713.1517.4221.15
Short-Term Debt
-123.0943.0476.1973.42166.94
Current Portion of Long-Term Debt
-5.331.613.9210.949.62
Current Portion of Leases
-3.612.356.461.910.12
Current Income Taxes Payable
-11.95--19.4612.72
Current Unearned Revenue
-117.4352.4627.2117.5625.02
Other Current Liabilities
-2.61---0-
Total Current Liabilities
-482.99400.53330.82320.68519.37
Long-Term Debt
-56.941.9535.9852.2731.06
Long-Term Leases
--4.242.368.820.38
Pension & Post-Retirement Benefits
-2.852.5721.891.89
Other Long-Term Liabilities
----00
Total Liabilities
-542.74449.29371.16383.66552.7

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
-260.92260.92107.19105.46105.46
Additional Paid-In Capital
-229.1229.11100.0280.7380.98
Retained Earnings
-201.13157.29149.11141.9275.89
Comprehensive Income & Other
--1.8472.0877.211.22
Shareholders' Equity
691.15691.15649.16428.4405.32263.54
Total Liabilities & Equity
-1,2341,098799.56788.98816.24

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
188.9188.9123.18134.92147.36208.11
Net Cash (Debt)
-174.6-177.82-106.08-120.35-142.07-196.49
Net Cash Growth
------
Net Cash Per Share
-1.34-1.36-0.84-1.12-1.27-1.86
Filing Date Shares Outstanding
130.46130.46130.46107.19105.46105.46
Total Common Shares Outstanding
130.46130.46130.46107.19105.46105.46
Working Capital
-646.64644.31414.38406.04244.92
Book Value Per Share
5.305.304.984.003.842.50
Tangible Book Value
683.29683.29639.93420.38396.76255.85
Tangible Book Value Per Share
5.245.244.913.923.762.43
Buildings
-7.257.257.257.257.25
Machinery
-16.7112.1411.5611.1410.11